| P50 | author | Hideo Yagita | Q89299610 |
| P2093 | author name string | Ko Okumura | |
| | Hajime Arai | |
| | Nobuhiko Kayagaki | |
| | Kiyoshi Sato | |
| | Makoto Hishii | |
| | Chinatsu Kasuga | |
| | Tomohiko Ebata | |
| P2860 | cites work | NF-kappaB signals induce the expression of c-FLIP. | Q39460566 |
| | Expression of TRAIL and its receptors in human brain tumors | Q40961600 |
| | Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 |
| | TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells | Q44265487 |
| | Apoptosis signaling by death receptors. | Q47751546 |
| | Human astrocytic brain tumors express AP02L/TRAIL. | Q48292518 |
| | Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) | Q57623656 |
| | Characterization of two receptors for TRAIL | Q24309064 |
| | The receptor for the cytotoxic ligand TRAIL | Q24310481 |
| | TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. | Q24314730 |
| | Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family | Q24315643 |
| | Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 |
| | The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain | Q24320162 |
| | Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway | Q24320210 |
| | Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 |
| | NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 |
| | An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 |
| | Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors | Q28245164 |
| | TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL | Q28248106 |
| | A novel receptor for Apo2L/TRAIL contains a truncated death domain | Q28255451 |
| | TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB | Q28259095 |
| | TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling | Q28267294 |
| | APO2 ligand: a novel lethal weapon against malignant glioma? | Q28272697 |
| | Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis | Q28369400 |
| | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | Q34469691 |
| | Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence | Q36707669 |
| P433 | issue | 10 | |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 840-844 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Cancer Science | Q326125 |
| P1476 | title | Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors. | |
| P478 | volume | 95 | |